Coastlands Capital Files Schedule 13G for Kalaris Therapeutics
A Schedule 13G filing identifies Coastlands Capital LP as the filer for Kalaris Therapeutics.
A Schedule 13G filing identifies Coastlands Capital LP as the filer for Kalaris Therapeutics.